Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,985 | 24,382 | 50,165 | 8,410 | 1,630 |
| Receivables | 684 | 23 | 23 | 53 | N/A |
| TOTAL | $18,766 | $25,758 | $51,941 | $8,714 | $1,732 |
| Non-Current Assets | |||||
| PPE Net | 670 | 547 | 582 | 569 | 594 |
| Investments And Advances | 1,000 | 1,000 | 0 | 0 | 0 |
| Intangibles | 2,044 | 2,044 | 2,044 | 2,044 | 2,044 |
| Other Non-Current Assets | 9,045 | 10,045 | 10,143 | 9,372 | 8,536 |
| TOTAL | $12,759 | $13,636 | $12,769 | $11,985 | $11,174 |
| Total Assets | $31,525 | $39,394 | $64,710 | $20,698 | $12,906 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 310 | 232 | 116 |
| Accounts payable and accrued liabilities | 1,755 | 996 | 3,679 | 1,812 | 1,275 |
| Accrued Expenses | 1,249 | 2,129 | 1,916 | 1,160 | 1,051 |
| Other current liabilities | 247 | 618 | 985 | N/A | N/A |
| TOTAL | $3,677 | $4,561 | $7,685 | $3,902 | $3,125 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 78 | 194 |
| Other Non-Current Liabilities | 2,345 | 19,383 | 21,842 | 21,140 | 1,928 |
| TOTAL | $2,345 | $21,794 | $21,842 | $21,217 | $2,122 |
| Total Liabilities | $6,022 | $26,354 | $29,527 | $25,119 | $5,247 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 192 | 174 | 173 | 139 | 5 |
| Common Shares | 13 | 260 | 224 | 208 | 25,800 |
| Retained earnings | -140,702 | -151,232 | -65,176 | -55,083 | -18,141 |
| Other shareholders' equity | 0 | 1 | 1 | 1 | 0 |
| TOTAL | $25,503 | $13,040 | $35,183 | $-4,421 | $7,659 |
| Total Liabilities And Equity | $31,525 | $39,394 | $64,710 | $20,698 | $12,906 |